Adaptimmune Therapeutics plc ADR (473A)
Market Open
14 Aug, 06:01
XSTU 
€
0. 01
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
40,000 Volume
-0.44 Eps
€ 0.01
Previous Close Want to track 473A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
473A Earnings Reports FAQ
What is the earnings per share (EPS) for 473A?
The current EPS is -0.44.
What is the company's earnings growth rate?
Adaptimmune Therapeutics plc ADR has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Adaptimmune Therapeutics plc ADR has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Adaptimmune Therapeutics plc ADR are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 473A at this time, as Adaptimmune Therapeutics plc ADR has no recent EPS data to calculate it.
